company background image
ALMIB logo

Amoéba ENXTPA:ALMIB Stock Report

Last Price

€0.76

Market Cap

€37.9m

7D

-2.1%

1Y

83.9%

Updated

06 Dec, 2024

Data

Company Financials +

ALMIB Stock Overview

Develops biological biocides for the prevention of microbiological risk for water, crop protection and health sectors. More details

ALMIB fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Amoéba S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Amoéba
Historical stock prices
Current Share Price€0.76
52 Week High€0.92
52 Week Low€0.36
Beta-0.12
11 Month Change10.72%
3 Month Change43.07%
1 Year Change83.87%
33 Year Change-27.31%
5 Year Change48.93%
Change since IPO-91.50%

Recent News & Updates

Recent updates

Amoéba (EPA:ALMIB) Is Carrying A Fair Bit Of Debt

Oct 14
Amoéba (EPA:ALMIB) Is Carrying A Fair Bit Of Debt

Is Amoéba (EPA:ALMIB) A Risky Investment?

Apr 28
Is Amoéba (EPA:ALMIB) A Risky Investment?

Does Amoéba (EPA:ALMIB) Have A Healthy Balance Sheet?

Oct 20
Does Amoéba (EPA:ALMIB) Have A Healthy Balance Sheet?

Does Amoéba (EPA:ALMIB) Have A Healthy Balance Sheet?

Apr 29
Does Amoéba (EPA:ALMIB) Have A Healthy Balance Sheet?

Shareholder Returns

ALMIBFR ChemicalsFR Market
7D-2.1%2.9%3.1%
1Y83.9%0.4%-2.6%

Return vs Industry: ALMIB exceeded the French Chemicals industry which returned 0.9% over the past year.

Return vs Market: ALMIB exceeded the French Market which returned -2.7% over the past year.

Price Volatility

Is ALMIB's price volatile compared to industry and market?
ALMIB volatility
ALMIB Average Weekly Movement7.4%
Chemicals Industry Average Movement5.4%
Market Average Movement4.6%
10% most volatile stocks in FR Market10.0%
10% least volatile stocks in FR Market2.3%

Stable Share Price: ALMIB's share price has been volatile over the past 3 months compared to the French market.

Volatility Over Time: ALMIB's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of French stocks.

About the Company

FoundedEmployeesCEOWebsite
201022Jean-Francois Doucetamoeba-nature.com

Amoéba S.A. develops biological biocides for the prevention of microbiological risk for water, crop protection and health sectors. It develops applications using amoeba Willaertia magna C2c Maky. The company was incorporated in 2010 and is based in Chassieu, France.

Amoéba S.A. Fundamentals Summary

How do Amoéba's earnings and revenue compare to its market cap?
ALMIB fundamental statistics
Market cap€37.91m
Earnings (TTM)-€13.42m
Revenue (TTM)n/a

0.0x

P/S Ratio

-2.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ALMIB income statement (TTM)
Revenue€0
Cost of Revenue€1.28m
Gross Profit-€1.28m
Other Expenses€12.15m
Earnings-€13.42m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.27
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio-122.1%

How did ALMIB perform over the long term?

See historical performance and comparison